Company / Working Capital
Yubo International Biotech Ltd Working Capital History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$2.1M
FY2025
5-year range
-$4.0M / $631.5K
FY2021-FY2025
Trend
+47.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 3 years of decline, reaching -$2M.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from -$3M to -$2M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 47.4% year-over-year.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.1M | +47.4% |
| FY2024 | -$4.0M | -51.3% |
| FY2023 | -$2.7M | -50.6% |
| FY2022 | -$1.8M | -380.8% |
| FY2020 | $631.5K | +138.0% |
| FY2019 | -$1.7M | -9.8% |
| FY2018 | -$1.5M | -10.5% |
| FY2017 | -$1.4M | -9.1% |
| FY2016 | -$1.3M | -11.5% |
| FY2015 | -$1.1M | -56.9% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026